BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 31053477)

  • 21. Prognostic factors in patients with middle and distal bile duct cancers.
    Kwon HJ; Kim SG; Chun JM; Lee WK; Hwang YJ
    World J Gastroenterol; 2014 Jun; 20(21):6658-65. PubMed ID: 24914391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma.
    Orimo T; Kamiyama T; Mitsuhashi T; Kamachi H; Yokoo H; Wakayama K; Shimada S; Nagatsu A; Taketomi A
    J Gastroenterol; 2018 Nov; 53(11):1206-1215. PubMed ID: 29721628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma.
    Sposito C; Ratti F; Cucchetti A; Ardito F; Ruzzenente A; Di Sandro S; Maspero M; Ercolani G; Di Benedetto F; Guglielmi A; Giuliante F; Aldrighetti L; Mazzaferro V
    J Hepatol; 2023 Feb; 78(2):356-363. PubMed ID: 36328332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral infiltration of intrahepatic cholangiocarcinoma is most prognostic after curative resection - Retrospective cohort study of 102 consecutive liver resections from a single center.
    Bartsch F; Baumgart J; Hoppe-Lotichius M; Schmidtmann I; Heinrich S; Lang H
    Int J Surg; 2018 Jul; 55():193-200. PubMed ID: 29803768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications.
    Hasegawa S; Ikai I; Fujii H; Hatano E; Shimahara Y
    World J Surg; 2007 Jun; 31(6):1256-63. PubMed ID: 17453285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
    de Jong MC; Nathan H; Sotiropoulos GC; Paul A; Alexandrescu S; Marques H; Pulitano C; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Bauer TW; Walters DM; Gamblin TC; Nguyen KT; Turley R; Popescu I; Hubert C; Meyer S; Schulick RD; Choti MA; Gigot JF; Mentha G; Pawlik TM
    J Clin Oncol; 2011 Aug; 29(23):3140-5. PubMed ID: 21730269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.
    Aoba T; Ebata T; Yokoyama Y; Igami T; Sugawara G; Takahashi Y; Nimura Y; Nagino M
    Ann Surg; 2013 Apr; 257(4):718-25. PubMed ID: 23407295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis.
    Yan Y; Lu N; Tian W; Liu T
    Tumori; 2014; 100(6):e250-6. PubMed ID: 25688507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary trends and outcomes after liver transplantation and resection for intrahepatic cholangiocarcinoma.
    Howell TC; Rhodin KE; Shaw B; Bao J; Kanu E; Masoud S; Bartholomew AJ; Gao Q; Anwar IJ; Ladowski JM; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Barbas AS; Lidsky ME
    J Gastrointest Surg; 2024 May; 28(5):738-745. PubMed ID: 38704208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.
    Kim HJ; Kim CY; Hur YH; Koh YS; Kim JC; Kim HJ; Cho CK
    Surg Today; 2014 Oct; 44(10):1879-86. PubMed ID: 24535697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges of surgical management of intrahepatic cholangiocarcinoma.
    Squires MH; Cloyd JM; Dillhoff M; Schmidt C; Pawlik TM
    Expert Rev Gastroenterol Hepatol; 2018 Jul; 12(7):671-681. PubMed ID: 29911912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis.
    Yadav S; Xie H; Bin-Riaz I; Sharma P; Durani U; Goyal G; Borah B; Borad MJ; Smoot RL; Roberts LR; Go RS; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Aug; 45(8):1432-1438. PubMed ID: 30914290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma.
    Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS
    World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients.
    Lang H; Sotiropoulos GC; Sgourakis G; Schmitz KJ; Paul A; Hilgard P; Zöpf T; Trarbach T; Malagó M; Baba HA; Broelsch CE
    J Am Coll Surg; 2009 Feb; 208(2):218-28. PubMed ID: 19228533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
    Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival of Patients with Cholangiocarcinoma Receiving Surgical Treatment in an O. viverrini Endemic Area in Thailand: A Retrospective Cohort Study.
    Chansitthichok S; Chamnan P; Sarkhampee P; Lertsawatvicha N; Voravisutthikul P; Wattanarath P
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):903-909. PubMed ID: 32334449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implication of tumor site in terms of node metastasis for intrahepatic cholangiocarcinoma.
    Lee W; Jeong CY; Jang JY; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Ryu JH; Yang K; Choi CS; Park YH; Nah YW; Kim R; Navarro J; Han DH; Choi GH; Kang CM; Kim KS; Hong SC
    Eur J Surg Oncol; 2020 May; 46(5):832-838. PubMed ID: 31806519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
    Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-grade dysplasia/carcinoma in situ of the bile duct margin in patients with surgically resected node-negative perihilar cholangiocarcinoma is associated with poor survival: a retrospective study.
    Higuchi R; Yazawa T; Uemura S; Izumo W; Furukawa T; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Aug; 24(8):456-465. PubMed ID: 28547855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.